No Data
No Data
Intellia Therapeutics, Inc. (NTLA): Pioneering Gene Editing Solutions for Health Advancements
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Genmab (GMAB) and Xoma (XOMA)
Maintaining Hold on Intellia Therapeutics Amid Financial Stability and Competitive Pressures
Intellia Therapeutics (NTLA) Receives a Buy From J.P. Morgan
Expert Ratings For Intellia Therapeutics
Express News | JP Morgan Maintains Overweight on Intellia Therapeutics, Lowers Price Target to $55
10baggerbamm : why is anybody even bothering with this woman she's been negative year-to-date she is no conviction she gives price targets pie in the sky and if she really believed in them she would not be selling these companies she's full of shit she made money one year one time everything else has been a disaster
tankeng : yes this woman has problems and arrogant
OhNowGombie : Another quack you mean? Totally out of her gourd too